Eaton Vance Management Cytokinetics Inc Transaction History

Eaton Vance Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $60,818 - $94,070	-2,045 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $10,270 - $13,867	299 Added 17.12%	2,045 $0
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $2,076 - $4,002	112 Added 6.85%	1,746 $0
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $26,162 - $35,680	1,322 Added 423.72%	1,634 $32,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $5,793 - $8,012	312 New	312 $7,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.